key: cord-0832910-bsz2lda6
authors: Nasiri, Mohammad Javad; Haddadi, Sara; Tahvildari, Azin; Farsi, Yeganeh; Arbabi, Mahta; Hasanzadeh, Saba; Jamshidi, Parnian; Murthi, Mukunthan; Mirsaeidi, Mehdi
title: COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis
date: 2020-03-26
journal: nan
DOI: 10.1101/2020.03.24.20042903
sha: f69509401b6d8e8593023f01b4d41edfc2de1d0c
doc_id: 832910
cord_uid: bsz2lda6

Objectives: The rapidly evolving coronavirus disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on March 11, 2020. It was first detected in the city of Wuhan in China and has spread globally resulting in substantial health and economic crisis in many countries. Observational studies have partially identified the different aspects of this disease. Up to this date, no comprehensive systematic review for the clinical, laboratory, epidemiologic and mortality findings has been published. We conducted this systematic review and meta-analysis for a better understanding of COVID-19. Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020. Statistical analyses were performed with STATA (version 14, IC; Stata Corporation, College Station, TX, USA). The pooled frequency with 95% confidence intervals (CI) was assessed using random effect model. Publication bias was assessed and p <0.05 was considered a statistically significant publication bias. Results: Out of 1102 studies, 32 satisfied the inclusion criteria. A total of 4789 patients with a mean age of 49 years were evaluated. Fever (83.0%, CI 77.5 to 87.6), cough (65.2%, CI 58.6 to 71.2) and myalgia/fatigue (34.7, CI 26.0 to 44.4) were the most common symptoms. The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8). Among the laboratory abnormalities, elevated C-Reactive Protein (CRP) (72.0% (CI 54.3 to 84.6) and lymphopenia (50.1%, CI 38.0 to 62.4) were the most common findings. Bilateral ground-glass opacities (66.0%, CI 51.1 to 78.0) was the most common CT-Scan presentation. Pooled mortality rate was 6.6%, with males having significantly higher mortality compared to females (OR 3.4; 95% CI 1.2 to 9.1, P = 0.01). Conclusion: COVID-19 commonly presented with a progressive course of cough and fever with more than half of hospitalized patients showing leukopenia or a high CRP on their laboratory findings. Mortality associated with COVID19 was higher than that reported in studies in China with Males having a 3-fold higher risk of mortality in COVID19 compared to females.

presentation. Pooled mortality rate was 6.6%, with males having significantly higher mortality 127 compared to females (OR 3.4; 95% CI 1.2 to 9.1, P = 0.01). 128

Conclusion: COVID-19 commonly presented with a progressive course of cough and fever with 129 more than half of hospitalized patients showing leukopenia or a high CRP on their laboratory 130 findings. Mortality associated with COVID19 was higher than that reported in studies in China 131

with Males having a 3-fold higher risk of mortality in COVID19 compared to females. 132 133

What is already known in this topic: 135

• COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. 136 • Many observational studies have separately dealt with different clinical and epidemiologic 137 features of this new and rapidly evolving disease. 138

• Very few systematic reviews about COVID-19 have been done and there was still a need 139 for a systematic review and meta-analysis related to the clinical findings and the mortality 140 of the disease in order to have a better understanding of COVID-19. 141

• Previous reports have indicated that older age and presence of multiple comorbidities are 142 associated with increased mortality. 143

What this study adds: 144 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org/10.1101/2020.03.24.20042903 doi: medRxiv preprint

• The mortality rate in our study for hospitalized COVID-19 patients was 6.6% and males 145 had around 3-fold higher risk of mortality compared to females (OR 3.4; 95% CI 1. 2 unknown cause was identified in the city of Wuhan. Since then, it has infected hundreds of 175 thousands of people around the world and resulted in more than 13000 deaths up to this date (4) . 176

Despite governmental travel restrictions in many countries, the confirmed number of new cases 177 has been rising globally. The international community has asked for at least US$675 million for 178 preparedness and protection of states with weaker health systems (5) . 179 180 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org /10.1101 /10. /2020 In the previous two outbreaks of coronaviral respiratory illness, namely Severe Acute Respiratory 181 Illness (SARS) and Middle East Respiratory Illness (MERS), gender-based difference in mortality 182 was observed. In SARS, younger males were at twice the risk of death compared to females and 183 the difference in mortality reduced with older age (6) . The case fatality rate observed in males was 184 twice that of females in MERS (7) . The effect of sex on COVID-19 mortality was unknown. We 185 evaluated this risk for COVID-19 patients as well. 186

The novelty of COVID19 has raised many questions about the epidemiology of the disease, 188 clinical and laboratory methods of diagnosis as well as therapeutic measures. Thus far, many 189 observational studies have been dealing with these features separately, however, there is still a 190 necessity for more systematic reviews specially to understand role of the sex in mortality of 191 (8) . The study did not require any ethics committee approval. 204

This research was done without patient involvement. Patients were not invited to comment on the 205 study design and were not consulted to develop patient relevant outcomes or interpret the results. 206

Patients were not invited to contribute to the writing or editing of this document for readability or 207 accuracy. 208

The records found through database searching were merged and the duplicates were removed 210 using EndNote X7 (Thomson Reuters, New York, NY, USA). Two reviewers (YF and PJ) 211 independently screened the records by title and abstract to exclude those not related to the current 212 study. The full texts of potentially eligible records were retrieved and evaluated by a third reviewer 213 (AT). Included studies met the following inclusion criteria: (i) patients were confirmed and 214 diagnosed with RT-PCR as suggested by WHO; (ii) The raw data for clinical, radiological and 215 laboratory findings were included; and (iii) the outcomes were addressed. Studies with insufficient 216 information about patients' characteristics and outcomes were excluded. Case reports, reviews, 217 and animal studies were also excluded. Only studies written in English were selected. 218

Data extraction and quality assessment 219 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org/10.1101/2020.03.24.20042903 doi: medRxiv preprint A data extraction form was designed by two reviewers (AZ and SH). These reviewers extracted 220 the data from all eligible studies and differences were resolved by consensus. The following data 221 were extracted: first author name; year of publication; type of study, country/ies where the study 222 was conducted; distribution of age and sex in the population, number of patients investigated, 223 data for clinical, radiological and laboratory findings, and outcomes. 224

Statistical analyses were performed with STATA (version 14, IC; Stata Corporation, College 226

Station, TX, USA). The pooled frequency with 95% confidence intervals (CI) was assessed using 227 random effect model. The between-study heterogeneity was assessed by Cochran's Q and the 228 I2 statistic. Publication bias was assessed statistically by using Begg's and Egger's tests (p<0.05 229 was considered indicative of statistically significant publication bias). 230

The checklist provided by the Joanna Briggs Institute (JBI) was used to perform quality 232 assessment (9) . 233 234

The search yielded 1102 publications, of which 259 potentially eligible studies were identified for 236

full-text review, resulting in 32 studies fulfilling the inclusion criteria ( Figure 1 ) (Table1). The mean 237 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Table 2) . 244

The most common comorbidities were respectively hypertension (18.5 %, CI 12.7-24.4), 246 cardiovascular diseases (14.9 %, CI 6.0-23.8), diabetes (10.8 %, CI 8.3-13.3), chronic liver 247 disease (8.1, CI 4.6-11.6) and smoking (8.0%, CI 2.3-13.6) ( Table 3) . 248

The most frequent abnormal laboratory findings in patients with COVID-19 were respectively, 250 (Table 4) . 253

Among the confirmed COVID19 subjects, 14.0% (CI, 6.7-29.0) had viremia. Impaired hepatic 254 function with ALT levels greater than 47.25 U/L was seen in 13.3% (CI 3.2-41.0) of COVID19 255 subjects. Acute cardiac injury with troponin levels greater than 28 pg/ml was seen in 12.4% of 256 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2020. (Table 5) . 267

Hospitalization was required in 94.6% of patients with severe COVID-19. The pooled mortality 269 rate of these patients was about 6.6% (CI 2.8-15.0) ( Table 6, Table 8 , men had significantly higher mortality in the hospital compared to women (OR 3.4; 274 95% CI 1.2-9.1, P = 0.01). Although ICU admission was higher in men, the difference was not 275 significant. The mean duration between the time of hospitalization and death was 17.5 days with 276 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org/10.1101/2020.03.24.20042903 doi: medRxiv preprint minimum and maximum periods of 14 and 21 days respectively. The effects and summaries 277 calculated using a random-effects model weighted by the study population is shown in Figure 2 . were the most common imaging modalities used for the diagnosis. The pooled sensitivity of CT-288 san for COVID19 was 79.3%. We found 20.7% of the patients with confirmed RT-PCR who had 289 normal chest CT-Scan suggesting that a normal chest CT-scan cannot rule out the disease in 290 patients who are highly suspicious for COVID-19. Several complications were seen due to 291 COVID-19. Among these, acute hepatitis was the most common one occurring in 13.3% of cases, 292 followed by cardiac injury with troponin levels greater than 28 pg/ml seen in 12.4%. The pooled 293 mortality rate of these patients was 6.6%. We detected several factors contributing to a worse 294 outcome including old age, male sex, presence of underlying diseases and some abnormal 295 laboratory finding such as high level of D-Dimer. Although there was not any significant difference 296 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2020. The current study showed that fever (83.0%), cough (65.2%) and dyspnea (27.4%) were the most 300 common signs and symptoms. In a study done by Zhang et al in Wuhan, fever was identified as 301 the most common clinical finding present in 91.7% of the patients followed by cough in 75% of 302 patients. Their study showed a higher gastrointestinal (GI) manifestation at presentation of the 303 disease, representing 39.6% of the patients (10) . Our study showed a lower prevalence of GI 304 symptoms including diarrhea, which was present in 5.7% of patients and nausea/vomiting in 5%. 305

The most prevalent comorbidities in our study were hypertension (18.5 %, CI 12.7-24.4) followed 307 by cardiovascular diseases (14.9 %, CI 6.0-23.8) and diabetes (10.8 %, CI 8.3-13.3). According 308 to a systematic review for comorbidities by Yang et al, hypertension (17 ± 7%, CI 14-22%) and 309 diabetes (8 ± 6%, CI 6-11%), followed by cardiovascular diseases (5 ± 4%, CI 4-7%) were the 310 most common comorbid findings (11) . The high prevalence of hypertension and other . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org/10.1101/2020.03.24.20042903 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org/10.1101/2020.03.24.20042903 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2020. . https://doi.org/10.1101/2020.03.24.20042903 doi: medRxiv preprint

Responding to Covid-19 -A Once-in-a-Century Pandemic?

COVID-19) situation summary: Center for Disease Control and Prevention

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Coronavirus Dashboard (GEOG 4046 example) 2020

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?

The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The Joanna Briggs institute reviewers' manual 2014. The systematic review of prevalence and incidence data Adelaide: The Joanna Briggs Institute

Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan

Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis

Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza

Clinical significance of lymphocytopenia in patients hospitalized with pneumonia caused by influenza virus

Viral load of SARS-CoV-2 in clinical samples. The Lancet Infectious Diseases

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

CT imaging features of 2019 novel coronavirus (2019-nCoV)

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

Clinical characteristics of coronavirus disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese medical journal

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases

A Novel Coronavirus from Patients with Pneumonia in China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

Persons Evaluated for 2019 Novel Coronavirus-United States

Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to duration of infection

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China

Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity

Hong Kong and implications for further spread